One of the early events in physiological shock is the generation of activators for leukocytes, endothelial cells, and other cells in the cardiovascular system. The mechanism by which these activators are produced has remained unresolved. We examine here the hypothesis that pancreatic digestive enzymes in the ischemic intestine may be involved in the generation of activators during intestinal ischemia. The lumen of the small intestine of rats was continuously perfused with saline containing a broadly acting pancreatic enzyme inhibitor (6-amidino-2-naphthyl p-guanidinobenzoate dimethanesulfate, 0.37 mM) before and during ischemia of the small intestine by splanchnic artery occlusion. This procedure inhibited activation of circulating leukocytes during occlusion and reperfusion. It also prevented the appearance of activators in portal venous and systemic artery plasma and attenuated initiating symptoms of multiple organ injury in shock. Intestinal tissue produces only low levels of activators in the absence of pancreatic enzymes, whereas in the presence of enzymes, activators are produced in a concentration-and time-dependent fashion. The results indicate that pancreatic digestive enzymes in the ischemic intestine serve as an important source for cell activation and inflammation, as well as multiple organ failure.rat ͉ splanchnic arterial occlusion ͉ shock ͉ multiple organ failure ͉ microcirculation S hock is a life-threatening cardiovascular complication (1). Cellular activation in the circulation is a relatively early event in shock that can be detected by leukocyte or endothelial superoxide production, pseudopod projection, expression of membrane adhesion molecules, and many other cell functions (2, 3). Cell activation fundamentally alters the biomechanics of microvascular blood flow by a shift in rheological, adhesive, and cytotoxic cell properties. The interaction between activated leukocytes and endothelial cells is followed by cell and organ failure (4). The level of activation correlates with survival after the shock (5), but the mechanism for production and the source of activating factors has remained an unresolved problem. Several candidates have been proposed, including endotoxins, lipid-derived products, and cytokines (6-9).Recently, we have demonstrated that the supernatant of the homogenized pancreas, but less so homogenates of other organs, mediates a powerful activation of cardiovascular cells (10). Incubation of homogenates from nonactivating organs, such as the liver or intestine, with low concentration of serine proteases also increases the ability to activate leukocytes. An enzyme inhibitor could block the activation, suggesting that pancreatic enzymes may play a central role in the production of activating factors.Pancreatic enzymes are discharged via the pancreatic duct into the duodenum and intestine as a requirement for digestion. We hypothesize that pancreatic enzymes in the ischemic intestine may be involved in the production of activating factors for circulatory cells in shock. Ischemia ...